FINWIRES · TerminalLIVE
FINWIRES

Arovella Therapeutics Secures Ethics Approval for First-in-Human Study of Blood Cancer Drug Candidate

By

Arovella Therapeutics (ASX:ALA) received ethics approval from The Alfred and Bellberry Human Research Ethics Committees to begin its phase 1 first-in-human clinical trial of ALA-101 drug candidate, a chimeric antigen receptor invariant natural killer T (CAR-iNKT) cell therapy for patients with relapsed or refractory lymphomas and leukemias, according to a Thursday Australian bourse filing.

The trial is expected to involve up to seven clinical sites across Australia and New Zealand, the filing said. It will evaluate the safety, tolerability, and preliminary anti-tumor activity of ALA-101.

The company remains on track to begin first patient dosing in the September quarter.

Arovella Therapeutics' shares fell past 1% in recent trading on Thursday and earlier hit their lowest since September 2023.

Related Articles

Wire

Cerebras Systems Q1 Net Loss Narrows, Revenue Rises; Shares Fall After Hours

Cerebras Systems (CBRS) reported a Q1 net loss late Tuesday of $0.22 per diluted share, narrowing from the loss of $0.46 a year earlier.Analysts polled by FactSet expected a loss of $0.16.Revenue in the three months ended March 31 rose to $193.4 million from $99.5 million a year earlier.Analysts expected $181.2 million.The company expects Q2 non-GAAP revenue of about $194 million. Analysts project $177.7 million.Cerebras expects full-year non-GAAP revenue of $855 million to $865 million. Analysts forecast $828 million.Cerebras shares fell 7.6% in after-hours trading.

$CBRS
Wire

Top Cryptocurrencies Fall; Bitcoin Drops Below $63,000 Level

Top cryptocurrencies fell Tuesday, with Bitcoin (BTC-USD) dropping below the $63,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 3.5% in the past 24 hours. The Nasdaq 100 fell 3.2%, the S&P 500 decreased 1.3%, and the Dow Jones Industrial Average was down 0.1%.Bitcoin dropped 3.2% to $62,259, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 9.5% to $29.78 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, declined 4.3% to $1,657.XRP (XRP-USD) dropped 2.7%, BNB (BNB-USD) fell 2.7%, and Solana (SOL-USD) lost 5.3%. Dogecoin (DOGE-USD) declined 5.1%, and Cardano (ADA-USD) shed 5.5%.The US 10-year Treasury yield stood at 4.509% at 3 p.m. ET Tuesday, up from 4.493% Monday, while the five-year yield rose to 4.288% from 4.261%.The total market value of the cryptocurrency industry fell 2.9% in the past 24 hours to $2.14 trillion, with trading volume rising 0.5% to $72.42 billion.Price: $62270.80, Change: $-1680.71, Percent Change: -2.63%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Cosmos Health to Deploy AI-Powered Call Center at Pharma Distribution Unit

Cosmos Health (COSM) said Tuesday its pharmaceutical distribution subsidiary CosmoFarm will deploy an artificial intelligence-powered call center to support customer communications, order intake and routine support functions.The platform will include multilingual voice assistance, intelligent call routing, outbound campaign automation, back-end system integration and real-time reporting capabilities, the company said.

$COSM